Back
ESC Premium Access

Zebrafish models for arrhythmogenic cardiomyopathy type 8: a starting platform for exercise stress test and drug treatment

Session: Novel anti-arrhythmic therapies
Topic: Cardiomyopathies
Speaker: Doctor G. Beffagna (Padova, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Giorgia Beffagna

Padova (Italy)
0 follower

5 more presentations in this session

Gene therapy for cardiac conduction system dysfunction in heart failure

Speaker: Mr L. Stuart (Manchester, GB)

Access
Abstract
Like
Thumbnail

Low dose of quinidine is effective to normalize the slow inactivation in mutant Kv4.3 channel identified in an early repolarization syndrome patient

Speaker: Doctor K. Takayama (Suita, JP)

Access
Abstract
Slides
Like
Thumbnail

Antiarrhythmic effects of Sacubitrilat (LBQ657) on Ca2+ homeostasis in ventricular cardiomyocytes

Speaker: Doctor J. Eiringhaus (Hannover, DE)

Access
Abstract
Like
Thumbnail

Carvedilol treatment diminishes spontaneous calcium release and electrical activity in human atrial myocytes

Speaker: Ms V. Jimenez Sabado (Barcelona, ES)

Access
Abstract
Like
Thumbnail

Dantrolene reduces CaMKII-mediated arrhythmogenesis

Speaker: Doctor J. Mustroph (Regensburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel anti-arrhythmic therapies

Speakers: Doctor G. Beffagna, Mr L. Stuart, Doctor K. Takayama, Doctor J. Eiringhaus, Ms V. Jimenez Sabado...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources